Short answer · Medically reviewed summary · Last updated: 2026-05-08
19q13.11 Microdeletion Syndrome is primarily known by its cytogenetic location and is also referred to as 19q13.11 deletion syndrome or del(19)(q13.11). Because this is a rare chromosomal anomaly, it does not currently have a widely used eponym or historical name, and the medical community prefers the descriptive cytogenetic terminology to ensure clinical accuracy. Why does 19q13.11 Microdeletion Syndrome have different names? In medical literature, 19q13.11 Microdeletion Syndrome is often identified by the specific chromosomal coordinates affected.
19q13.11 Microdeletion Syndrome synonyms
Other names for 19q13.11 Microdeletion Syndrome: synonyms, acronyms and related terms used by doctors and patients.
19q13.11 Microdeletion Syndrome is primarily known by its cytogenetic location and is also referred to as 19q13.11 deletion syndrome or del(19)(q13.11). Because this is a rare chromosomal anomaly, it does not currently have a widely used eponym or historical name, and the medical community prefers the descriptive cytogenetic terminology to ensure clinical accuracy.
Why does 19q13.11 Microdeletion Syndrome have different names?
In medical literature, 19q13.11 Microdeletion Syndrome is often identified by the specific chromosomal coordinates affected. The use of multiple names—such as 19q13.11 deletion syndrome or 19q13.11 interstitial deletion—arises because clinicians and geneticists use slightly different descriptive styles to define the same structural variation. These names are not distinct conditions but are interchangeable labels used to describe the loss of genetic material on the long arm of chromosome 19.
How is 19q13.11 Microdeletion Syndrome classified?
The nomenclature for 19q13.11 Microdeletion Syndrome is standardized by international bodies to ensure consistent diagnosis. Key identifiers include:
- Orphanet: Listed as ORPHA:352554.
- OMIM: Frequently associated with specific gene loci within the 19q13.11 region.
- Cytogenetic Notation: Often documented in clinical reports as 46,XX,del(19)(q13.11) or similar, depending on the specific breakpoints identified via microarray analysis.
Which name should patients use?
Medical professionals currently prefer the term 19q13.11 Microdeletion Syndrome because it clearly indicates both the location of the deletion and the fact that it is a microdeletion, which typically requires chromosomal microarray (CMA) testing to detect. When speaking with specialists, using the term 19q13.11 Microdeletion Syndrome or providing the specific coordinates from your genetic report is the most effective way to ensure clear communication.
Next steps
- Consult with a clinical geneticist to interpret your specific microarray results.
- Connect with the 19 community members at DiseaseMaps.org who are living with 19q13.11 Microdeletion Syndrome to share resources.
- Request a referral to a genetic counselor to discuss family planning and inheritance patterns.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare provider for diagnosis and treatment.
References
- Orphanet: Rare Disease Database (ORPHA:352554)
- NIH Genetic and Rare Diseases (GARD) Information Center
- Online Mendelian Inheritance in Man (OMIM)
- DiseaseMaps.org community data
